Method Sign up free

Borrower record · Q2 2026

BioAgilytix

As filed by Crescent Capital BDC, Inc. · period end 30 June 2026No sector — one filer, nothing to corroborate

Crescent Capital BDC, Inc. is the only BDC lending to BioAgilytix: $14.7m across two positions at Q2 2026, marked at 88.1 cents. Two of the two positions pay interest in kind, the largest at 400bp.

Filed fair value
$14.7m
2 funded positions
Aggregate mark
88.1c
cost filed on all 2 positions
Maturities to
2028
one date, 1 December 2028
Periods on record
5
Q2 2025 → Q2 2026

How this total is counted

Pricing as filed

2 floating tranches · SOFR

650bp on all 2 floating tranches — every filer reports the same spread.

Capital structure

First-Lien Senior Secured, on all 2 positions whose seniority a filer disclosed.

Rate structure

Floating, on all 2 positions whose interest type a filer disclosed.

Maturity profile

all 2 funded positions dated
2028
$14.7m

2.4 years to maturity, weighted by fair value across the 2 dated positions.

Filed over time

5 periods · aggregate only

Filed fair value

$13.4m
Q2 2025
$13.4m
Q3 2025
$13.6m
Q4 2025
$14.6m
Q1 2026
$14.7m
Q2 2026

Aggregate marknot to zero

83.7c
Q2 2025
82.5c
Q3 2025
83.1c
Q4 2025
88.6c
Q1 2026
88.1c
Q2 2026

Q2 2025, Q3 2025, Q4 2025, Q1 2026, Q2 2026 — every filer reporting the borrower at each period, aggregated. No lender is separated out at any period.

Credit flags

Pays in kind2 positions at 1 lender carry a PIK component, the largest filed at 400bp, $14.7m of fair value.

Not in the filings

Sign up for free

Tell me when this changes.

One lender reports BioAgilytix today. We will email you when a second one does, when Crescent Capital BDC, Inc.'s mark moves, or when the position leaves the schedule.

Every filing behind this page

1 filer · Q2 2026
FilerCIKFormPeriodFiledAccession
Crescent Capital BDC, Inc. (CCAP)000163333610-Q2026-06-302026-08-100001193125-26-342351

Related borrowers

Same lender